These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 33193404)

  • 1. Identification of Immune Cell Infiltration and Immune-Related Genes in the Tumor Microenvironment of Glioblastomas.
    Huang S; Song Z; Zhang T; He X; Huang K; Zhang Q; Shen J; Pan J
    Front Immunol; 2020; 11():585034. PubMed ID: 33193404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mining TCGA database for genes of prognostic value in glioblastoma microenvironment.
    Jia D; Li S; Li D; Xue H; Yang D; Liu Y
    Aging (Albany NY); 2018 Apr; 10(4):592-605. PubMed ID: 29676997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma.
    DeCordova S; Shastri A; Tsolaki AG; Yasmin H; Klein L; Singh SK; Kishore U
    Front Immunol; 2020; 11():1402. PubMed ID: 32765498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an Immune-Related Prognostic Index Associated With Glioblastoma.
    Jiang Z; Shi Y; Zhao W; Zhang Y; Xie Y; Zhang B; Tan G; Wang Z
    Front Neurol; 2021; 12():610797. PubMed ID: 34093386
    [No Abstract]   [Full Text] [Related]  

  • 6. Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment.
    Jeanmougin M; Håvik AB; Cekaite L; Brandal P; Sveen A; Meling TR; Ågesen TH; Scheie D; Heim S; Lothe RA; Lind GE
    Mol Oncol; 2020 May; 14(5):1016-1027. PubMed ID: 32171051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated microenvironment-associated genomic profiles identify LRRC15 mediating recurrent glioblastoma-associated macrophages infiltration.
    Tang H; Liu W; Xu Z; Zhao J; Wang W; Yu Z; Wei M
    J Cell Mol Med; 2021 Jun; 25(12):5534-5546. PubMed ID: 33960636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The N
    Zhao R; Li B; Zhang S; He Z; Pan Z; Guo Q; Qiu W; Qi Y; Zhao S; Wang S; Chen Z; Zhang P; Guo X; Xue H; Li G
    Front Immunol; 2021; 12():653711. PubMed ID: 34354698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and validation of an immune-based prognostic score model in glioblastoma.
    Qin Z; Zhang X; Chen Z; Liu N
    Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development.
    Lin H; Wang K; Xiong Y; Zhou L; Yang Y; Chen S; Xu P; Zhou Y; Mao R; Lv G; Wang P; Zhou D
    Front Immunol; 2022; 13():773264. PubMed ID: 35185876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel Foxp3-related immune prognostic signature for glioblastoma multiforme based on immunogenomic profiling.
    Guo XY; Zhang GH; Wang ZN; Duan H; Xie T; Liang L; Cui R; Hu HR; Wu Y; Dong JJ; He ZQ; Mou YG
    Aging (Albany NY); 2021 Jan; 13(3):3501-3517. PubMed ID: 33429364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Immune-Related Genes Contributing to the Development of Glioblastoma Using Weighted Gene Co-expression Network Analysis.
    Kong Y; Feng ZC; Zhang YL; Liu XF; Ma Y; Zhao ZM; Huang B; Chen AJ; Zhang D; Thorsen F; Wang J; Yang N; Li XG
    Front Immunol; 2020; 11():1281. PubMed ID: 32765489
    [No Abstract]   [Full Text] [Related]  

  • 13. Grade II/III Glioma Microenvironment Mining and Its Prognostic Merit.
    Chen J; Hou C; Wang P; Yang Y; Zhou D
    World Neurosurg; 2019 Dec; 132():e76-e88. PubMed ID: 31518750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics analysis of microenvironment-related genes associated with radioresistance in glioblastoma.
    Liu Y; Zhao Y; Fang J; Fang J; Yuan X
    Transl Cancer Res; 2020 Dec; 9(12):7495-7504. PubMed ID: 35117350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGFBP2 promotes immunosuppression associated with its mesenchymal induction and FcγRIIB phosphorylation in glioblastoma.
    Liu Y; Song C; Shen F; Zhang J; Song SW
    PLoS One; 2019; 14(9):e0222999. PubMed ID: 31560714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.
    Li H; Wang D; Yi B; Cai H; Xi Z; Lou X; Li Z
    Biomed Res Int; 2021; 2021():8357585. PubMed ID: 34395626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 63 signature genes prediction system is effective for glioblastoma prognosis.
    Zhang Y; Xu J; Zhu X
    Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune microenvironments differ in immune characteristics and outcome of glioblastoma multiforme.
    Zhang B; Shen R; Cheng S; Feng L
    Cancer Med; 2019 Jun; 8(6):2897-2907. PubMed ID: 31038851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel immune cell signature for predicting glioblastoma after radiotherapy prognosis and guiding therapy.
    Huang R; Lu X; Sun X; Wu H
    Int J Immunopathol Pharmacol; 2024; 38():3946320241249395. PubMed ID: 38687369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.